UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED CONDENSED STATEMENT OF CASH FLOW (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Statement of Cash Flows
Net income	$ 5,368	$ 5,190
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	308	334
Amortization	1,273	1,305
(Gain) loss on investments
Provision for (recovery of) losses on accounts receivable	(1)	8
(Gain)/Loss on disposal of assets	(1)
Deferred income taxes	(357)	(428)
Stock-based compensation expense	14	38
Changes in operating assets and liabilities:
Accounts receivable - trade	(1,350)	(275)
Accrued interest and other receivables	(128)	(89)
Inventories	8	183
Prepaid expenses and other current assets	145	62
Accounts payable	(17)	429
Accrued expenses	169	(170)
Deferred revenue	(50)	(50)
Other liability	(339)
Total adjustments	(326)	1,347
Net cash provided by operating activities	5,042	6,537
Capital expenditures for property and equipment	(111)	(133)
Capital expenditures for intangible assets	(5)	(1)
Purchases of investments
Proceeds from sale of investments
Net cash (used in) provided by investing activities	(116)	(134)
Proceeds from issuance of common stock - options	490	978
Common stock purchased and retired
Payment of taxes for exchange of stock options	(90)
Tax benefit attributable to exercise of stock options	199	99
Repayment of notes payable	(1,935)	(5,221)
Payment of dividends	(911)	(878)
Net cash provided by (used in) financing activities	(2,246)	(5,021)
Effect of exchange rate changes on cash	(164)	(3)
NET INCREASE IN CASH	2,514	1,378
CASH AT BEGINNING OF PERIOD	8,871	6,534
CASH AT END OF PERIOD	11,385	7,913
Cash paid during the period for income taxes	1,634	2,021
Cash paid during the period for interest	$ 235	$ 360